DEUTSCHE BANK AG\ - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 191 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$8,068,000
-44.0%
53,372
-46.1%
0.01%
-37.5%
Q2 2022$14,416,000
-84.2%
98,932
-87.2%
0.01%
-81.4%
Q1 2022$91,401,000
-16.9%
770,867
-3.4%
0.04%
-12.2%
Q4 2021$109,969,000
+7.3%
797,980
+8.1%
0.05%0.0%
Q3 2021$102,512,000
+40.0%
737,971
-2.2%
0.05%
+36.1%
Q2 2021$73,227,000
+47.4%
754,294
+3.8%
0.04%
+33.3%
Q1 2021$49,668,000
+394.7%
726,680
+520.3%
0.03%
+350.0%
Q4 2020$10,041,000
-70.7%
117,153
-77.8%
0.01%
-75.0%
Q3 2020$34,305,000
-23.2%
527,690
-13.6%
0.02%
-29.4%
Q2 2020$44,645,000
+131.6%
610,647
+7.8%
0.03%
+100.0%
Q1 2020$19,273,000
-28.1%
566,333
+14.9%
0.02%0.0%
Q4 2019$26,823,000
+592.9%
492,757
+430.5%
0.02%
+466.7%
Q3 2019$3,871,000
-39.6%
92,881
-36.5%
0.00%
-25.0%
Q2 2019$6,407,000
-57.6%
146,351
-50.2%
0.00%
-55.6%
Q1 2019$15,110,000
+121.2%
293,595
+58.9%
0.01%
+80.0%
Q4 2018$6,832,000
-61.5%
184,766
-60.9%
0.01%0.0%
Q3 2018$17,761,000
+15.3%
473,017
+21.4%
0.01%
+25.0%
Q2 2018$15,401,000
+868.0%
389,746
+530.9%
0.00%
+300.0%
Q1 2018$1,591,000
+150.6%
61,778
+162.0%
0.00%
Q4 2017$635,000
-7.0%
23,580
+28.6%
0.00%
Q3 2017$683,000
+109.5%
18,332
+39.6%
0.00%
Q2 2017$326,00013,1310.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 900,844$136,181,00079.57%
RP Management, LLC 1,111,111$167,967,00077.60%
JET CAPITAL INVESTORS L P 1,707,500$258,942,00053.95%
Alpine Global Management, LLC 373,999$56,537,00013.23%
Chicago Capital Management, LLC 154,585$23,443,00012.75%
FIFTH LANE CAPITAL, LP 140,000$21,164,00011.03%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 3,784,482$572,100,000,00010.85%
Eversept Partners, LP 637,139$96,316,3038.35%
EQUITEC PROPRIETARY MARKETS, LLC 187,100$28,284,0007.45%
HARVEST MANAGEMENT LLC 48,503$7,332,0005.92%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders